Unilever To Revisit $65b Merger Deal With GSK
Unilever has signaled it will continue pursuing a blockbuster deal to buy GlaxoSmithKline’s (GSK) healthcare arm. Unilever has already had a £50b ($65b) offer rejected, but said on Monday a deal would be a “strong strategic fit”. GSK’s health products business...